Axa Has Lifted Its Teradyne INC (TER) Holding by $19.82 Million as Share Value Declined

October 13, 2018 - By Hazel Jackson

Teradyne, Inc. (NYSE:TER) LogoInvestors sentiment decreased to 0.62 in Q2 2018. Its down 0.49, from 1.11 in 2018Q1. It dropped, as 65 investors sold TER shares while 133 reduced holdings. 34 funds opened positions while 89 raised stakes. 180.08 million shares or 0.97% less from 181.84 million shares in 2018Q1 were reported. Highline Capital Mgmt Lp reported 2.09M shares. Granahan Mngmt Incorporated Ma invested in 0.16% or 69,514 shares. Laurion Capital Management Limited Partnership accumulated 182,547 shares. First Mercantile reported 15,973 shares. Gilman Hill Asset Mgmt Limited Liability has 0.22% invested in Teradyne, Inc. (NYSE:TER). Massmutual Com Fsb Adv has 100 shares for 0% of their portfolio. Essex Investment Mngmt Limited Liability Co invested in 0.1% or 21,157 shares. Liberty Mutual Group Asset Mngmt Incorporated holds 0.04% or 38,097 shares in its portfolio. Mastrapasqua Asset Mngmt holds 0.55% or 71,808 shares. Utah Retirement has invested 0.03% of its portfolio in Teradyne, Inc. (NYSE:TER). Susquehanna Int Gru Llp stated it has 157,226 shares. Advisory Ser Ltd Llc holds 15,888 shares or 0.05% of its portfolio. California State Teachers Retirement Sys stated it has 0.02% of its portfolio in Teradyne, Inc. (NYSE:TER). Blackrock Inc accumulated 18.22 million shares or 0.03% of the stock. State Of Alaska Department Of Revenue holds 20,280 shares or 0.01% of its portfolio.

Axa increased its stake in Teradyne Inc (TER) by 24.05% based on its latest 2018Q2 regulatory filing with the SEC. Axa bought 521,699 shares as the company’s stock declined 5.81% while stock markets rallied. The institutional investor held 2.69 million shares of the capital goods company at the end of 2018Q2, valued at $102.44 million, up from 2.17 million at the end of the previous reported quarter. Axa who had been investing in Teradyne Inc for a number of months, seems to be bullish on the $6.20B market cap company. The stock increased 1.84% or $0.6 during the last trading session, reaching $33.25. About 2.48 million shares traded. Teradyne, Inc. (NYSE:TER) has risen 1.58% since October 13, 2017 and is uptrending. It has underperformed by 14.04% the S&P500.

Axa, which manages about $26.09B US Long portfolio, decreased its stake in Myokardia Inc by 101,528 shares to 7,200 shares, valued at $357,000 in 2018Q2, according to the filing. It also reduced its holding in Kraft Heinz Co by 66,534 shares in the quarter, leaving it with 101,337 shares, and cut its stake in Brightsphere Investmnt Grp P.

More recent Teradyne, Inc. (NYSE:TER) news were published by: Globenewswire.com which released: “Teradyne Announces New TUGX Global Seminars” on October 10, 2018. Also Seekingalpha.com published the news titled: “Teradyne’s Cobot Opportunity More Than Just Hype” on October 04, 2018. Globenewswire.com‘s news article titled: “Teradyne Sponsors 19th Annual Korea Test Conference in Seoul, South Korea” with publication date: October 12, 2018 was also an interesting one.

Teradyne, Inc. (NYSE:TER) Ratings Coverage

Among 6 analysts covering Teradyne (NYSE:TER), 3 have Buy rating, 0 Sell and 3 Hold. Therefore 50% are positive. Teradyne had 7 analyst reports since April 25, 2018 according to SRatingsIntel. Stifel Nicolaus maintained it with “Buy” rating and $51 target in Thursday, April 26 report. The company was downgraded on Wednesday, April 25 by DA Davidson. The stock has “Outperform” rating by Robert W. Baird on Wednesday, October 10. Citigroup maintained Teradyne, Inc. (NYSE:TER) rating on Tuesday, September 25. Citigroup has “Buy” rating and $47 target. Credit Suisse maintained it with “Neutral” rating and $39 target in Thursday, April 26 report. The stock of Teradyne, Inc. (NYSE:TER) earned “Hold” rating by Robert W. Baird on Wednesday, April 25.

Teradyne, Inc. (NYSE:TER) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

>